Posts tagged Dry AMD
LumiThera Chooses bioaccess.™ as its Regulatory and Market Access Consultant to Sell its Innovative Valeda™ Light Delivery System in Colombia
LumiThera Chooses bioaccess.™ as its Regulatory and Market Access Consultant to Sell its Innovative Valeda™ Light Delivery System in Colombia

LumiThera, Inc. has chosen bioaccess.™ as its regulatory and market access partner to obtain marketing authorization and commercialize its innovative Valeda™ Light Delivery System in Colombia. Valeda™ is the first approved treatment for dry age-related macular degeneration using photobiomodulation (PBM). LumiThera is at the forefront of the development of  PBM treatments for patients with age-related macular degeneration and other degenerative ocular diseases.

Read More
Regulatory ConsultingJulio G. Martinez-ClarkLumiThera, Valeda Light Delivery System, Dry AMD, photobiomodulation, LT-300Comment